How to Create Multiple Healthcare Company Selling Offers Without a Public Auction

Key Takeaways

1. You can create real bidding pressure with a timed, confidential process—no public auction needed.
2. The buyer list matters more than buyer volume; targeted outreach beats “spray and pray.
3. A strong Quality of Earnings story reduces discounting and increases bids.
4. IOIs first, LOIs second—standardized bid templates make offers comparable and stronger.
5. Confidentiality and compliance readiness protect value in healthcare transactions.

Introduction

A public auction isn’t the only way to get multiple offers. The aim is “confidential competitive tension”: several qualified buyers evaluating the same package on the same deadlines. Start with exit planning that preserves optionality, so you’re not forced into one buyer’s terms.

The 4-step structure: Teaser → NDA → IOI → LOI

Use a blind teaser to spark interest without naming the company. After NDAs, share a tight deal package and set a firm IOI deadline. Then invite 2–4 finalists to submit LOIs. To keep momentum, follow early preparation playbooks that eliminate last-minute surprises.

Step 1 – Build a buyer list that produces bids

The best lists combine strategics, PE platforms, and add-on buyers, filtered by size, specialty fit, and financing. Avoid tire-kickers by using a “proof of capability” screen and a clear timeline—this is consistent with how a targeted sell-side M&A process is typically run. If buyers go silent, use this diagnostic on why buyers disappear to fix friction fast.

Make IOIs comparable, then upgrade to LOIs

Multiple offers happen when buyers can price quickly and confidently. Require IOIs to include price range, structure (cash vs rollover), assumptions, and timeline—using one template. Position optional structures (partial exit, recap, holdco) with founder optionality deal models. Demand remains active, as Bain notes in its 2026 healthcare PE report.

Step 2 — Create a CIM That Forces Clear, Comparable Offers

A strong CIM removes “pricing fog.” It explains what you do, why it’s defensible, and what a buyer is really buying. Use what buyers test in Quality of Earnings to pre-answer the questions that cause price cuts later.

What buyers need to price you quickly (and what triggers discounting)

The best lists combine strategics, PE platforms, and add-on buyers, filtered by size, specialty fit, and financing. Avoid tire-kickers by using a “proof of capability” screen and a clear timeline—because when more than one potential purchaser is involved, the process typically moves through defined stages that require disciplined sequencing and comparability (see PwC’s overview of the five stages of an M&A transaction.

The “risk narrative” checklist: compliance, payers, referrals, provider dependence

Healthcare deals die on unspoken risk. Spell out payer concentration, referral reliance, and compliance posture as strengths with mitigations—not as surprises. Use the CEO risk map to identify issues buyers will weaponize in diligence. Regulators are also watching healthcare roll-ups.

Step 3 — Use a Tight NDA + Teaser Strategy to Protect Confidentiality

Your teaser should be specific enough to attract the right buyers, but blind enough to protect staff, patients, and referrals. Follow MedBridge’s confidentiality playbook to control when identity is revealed and keep rumors from eroding value.

Step 4 — Run a Timed IOI Round to Create Real Competitive Tension

Set a deadline and require a standard IOI format so bids are comparable. This is how you get “multiple offers” without broadcasting an auction—because in a typical sell-side process, initial bids are often non-binding IOIs used to narrow the buyer list before LOIs (see BDO’s overview of how IOIs and LOIs fit into the M&A timeline). Use IOI vs LOI guidance> to avoid soft commitments that waste time.

Step 5 — Convert IOIs Into Clean, Higher LOIs

Multiple offers only matter if they stay alive through diligence. After IOIs, move fast with a finalist sprint: 48-hour Q&A windows, one data room, and one bid template. Use competitive tension plus IOI vs LOI discipline to prevent “soft” bids from wasting weeks.

Ask every finalist to state price, cash-at-close, rollover %, employment terms, exclusivity length, and key assumptions—so you can compare and counter objectively, in writing.

Pick finalists by certainty, not just price

Select 2–4 buyers with proof of funds, sector fit, and a clear timeline. If a bidder stalls, diagnose it with why buyers disappear and tighten deadlines. Active healthcare PE demand supports fast, competitive cycles.

Negotiate structure, not headlines

A slightly lower price with better structure can win: less earnout risk, clearer working-capital targets, and stronger reps/indemnities. One practical way to evaluate “structure vs headline” is understanding how working-capital and purchase price adjustments can change the true economics at closing (see KPMG’s overview of locked-box vs completion accounts and purchase price adjustments).

Keep confidentiality tight through diligence

Keeping confidentiality tight during diligence protects value. When you control disclosures and prevent leaks, you reduce disruption to staff, referrals, and operations—so buyers stay confident, timelines stay intact, and last-minute retrades become far less likely.

FAQs

1) Can I get multiple offers without telling buyers I’m running a process?

Yes. You create “silent competition” by using the same teaser/CIM package for everyone, setting firm deadlines, and requiring standardized IOIs and LOIs. Buyers feel the timeline pressure even if you never say “auction.”

2) How many buyers should I contact to reliably get 3+ offers?

A typical confidential process targets 15–40 qualified buyers (not 200). The right number depends on your specialty, EBITDA size, geography, and payer mix—but quality of fit drives offers, not volume.

3) What if I receive only one LOI after the IOI round?

Don’t stall. Immediately re-engage the next-best IOI bidders with a short finalist window (48–72 hours), tighten data room access, and fix the objections that caused drop-off (QoE clarity, provider dependence, compliance questions).

4) What increases bid strength fastest in healthcare deals?

Three things:

• Clean QoE story (credible add-backs, consistent margins)
  
• Lower key-person risk (provider coverage plan, retention, contracts)
  
• Comparable bid template (price + structure + assumptions + timeline)
  

5) What kills offers late in diligence (and causes retrades)?

Most retrades come from: slow/chaotic data room, unclear working-capital targets, payer/referral concentration surprises, compliance documentation gaps, and confidentiality leaks that disrupt staff or referral stability.